While most of the 433 climbers on McKinley are going up the normal route, one young American has made the first solo of the ...

Alex Eule is a deputy editor at Barron's. He has spent the past decade at Barron's covering stocks, with a focus on the media and technology sectors. Alex Eule is a deputy editor at Barron's. He ...

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases. The company develops Eclitasertib (SAR443122 ...

Kevin Chiu teaches courses in principles of microeconomics, principles of macroeconomics, and international economics, development, and growth. He received his Ph.D. in economics from Florida State ...

Denali Therapeutics' experimental drug for amyotrophic lateral sclerosis (ALS) failed to show efficacy in part of the phase 2/3 HEALEY ALS basket trial, causing a fall in its share price.

Alex’s reporting focuses in particular on the inner workings of the National Security Council and how top players in an administration formulate and execute foreign policy. Alex was previously ...

Today’s question: Which driver should worry Alex Palou the most in the NTT INDYCAR SERIES championship chase with nine races remaining? Curt Cavin: It seems to me Alex Palou’s battle is largely ...